Tianrong Internet Products and Services, Inc. (TIPS) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Tianrong Internet Products and Services, Inc. (TIPS) trades at $0.0002. Tianrong Internet Products and Services, Inc. operates as an investment company with a focus on the medical sector. Sector: Consumer cyclical.
Price as of Jul 20, 2026 · Last analyzed: Mar 18, 2026Analyst Coverage for TIPS: TIPS does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates TIPS against Consumer Cyclical peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
TIPS: 2/3 scored disciplines lean bearish. Dominant signal: Ray Dalio bullish.
How is this calculated? →Tianrong Internet Products and Services, Inc. (TIPS) Consumer Business Overview
Tianrong Internet Products and Services, Inc., based in Mountainhome, PA, functions as an investment entity targeting the medical industry, characterized by high gross margins (97.7%) but substantial net losses, operating as a subsidiary within the consumer cyclical sector, with a small team of two employees.
What Is the Investment Thesis for TIPS?
Tianrong Internet Products and Services, Inc. presents a complex investment profile. Its high gross margin of 97.7% suggests potential for profitability if operational costs are managed effectively. However, the negative profit margin of -273.0% indicates significant challenges in controlling expenses or generating sufficient revenue from its investments. The company's small size and subsidiary status imply reliance on Wilton Management Ltd. for strategic direction and financial support. Growth catalysts depend on successful investments in the medical sector, while risks include the volatility inherent in the medical industry and the potential for underperformance relative to its parent company's expectations. Investors should carefully evaluate the company's investment portfolio and its alignment with Wilton Management's overall strategy.
Based on FMP financials and quantitative analysis
TIPS Key Highlights
- High Gross Margin: The company boasts a gross margin of 97.7%, indicating a strong ability to generate revenue from its investments before considering operating expenses.
- Negative Profit Margin: Despite the high gross margin, the company's profit margin is -273.0%, highlighting significant operational inefficiencies or substantial losses from its investments.
- Subsidiary Status: Tianrong operates as a subsidiary of Wilton Management Ltd., which implies that its strategic decisions and financial resources are heavily influenced by its parent company.
- Small Team: With only two employees, the company likely outsources many of its operational functions, focusing primarily on investment selection and management.
- Medical Sector Focus: The company's investment strategy is centered on the medical sector, which offers both high-growth potential and significant regulatory and market risks.
Who Are TIPS's Competitors?
TIPS is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| FDIT Findit, Inc. | $0.03 | -14.86% | $30.1M | 63 |
| BZUN Baozun Inc. | $2.51 | +0.00% | $146M | 53 |
| VLTA Volta Inc. | $0.86 | -0.01% | $150M | 55 |
| YSG Yatsen Holding Limited | $3.52 | -1.40% | $330M | 56 |
| BBW Build-A-Bear Workshop, Inc. | $34.01 | -0.35% | $426M | 78 |
| BNED Barnes & Noble Education, Inc. | $12.60 | +0.00% | $437M | 71 |
| BWMX Betterware de México, S.A.P.I. de C.V. | $18.35 | +0.05% | $683M | 57 |
| HZO MarineMax, Inc. | $33.97 | -1.59% | $748M | 54 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are TIPS's Key Strengths?
- High gross margin (97.7%)
- Subsidiary of Wilton Management Ltd.
- Focus on the high-growth medical sector
- Long operating history (established in 1959)
What Are TIPS's Weaknesses?
- Negative profit margin (-273.0%)
- Small team (2 employees)
- Reliance on Wilton Management Ltd.
- Limited publicly available information
What Could Drive TIPS Stock Higher?
- Potential for strategic investments in high-growth medical companies.
- Support from Wilton Management Ltd. providing financial stability.
- Focus on the expanding medical sector driving potential revenue growth.
What Are the Key Risks for TIPS?
- Financial-distress signal — its Altman Z-Score of -13.28 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-3.3%) — the business is not currently generating profit on shareholder capital.
- Limited liquidity due to trading on the OTC Other market.
- Lack of financial transparency due to minimal reporting requirements.
- Negative profit margin indicating operational inefficiencies.
- Reliance on Wilton Management Ltd. for strategic direction.
- Volatility inherent in the medical industry impacting investment returns.
What Are the Growth Opportunities for TIPS?
- Strategic Investments in Emerging Medical Technologies: Tianrong can capitalize on the growing demand for innovative medical technologies by investing in companies developing cutting-edge solutions in areas such as gene therapy, personalized medicine, and robotic surgery. The global market for these technologies is projected to reach $500 billion by 2030, offering substantial growth potential. Success hinges on identifying companies with strong intellectual property, experienced management teams, and clear regulatory pathways.
- Expansion into Telehealth and Digital Health Solutions: The telehealth and digital health market is experiencing rapid growth, driven by increasing demand for remote patient monitoring, virtual consultations, and digital therapeutics. Tianrong can invest in companies that are developing innovative solutions in these areas, targeting a market expected to reach $300 billion by 2028. This strategy requires careful assessment of regulatory compliance, data security, and patient adoption rates.
- Focus on Medical Device Companies with Breakthrough Technologies: Investing in medical device companies that are developing breakthrough technologies can provide significant returns. The global medical device market is projected to reach $600 billion by 2027, with innovative devices driving much of the growth. Tianrong should focus on companies with strong patent portfolios, clinical validation, and clear market access strategies.
- Targeted Investments in Healthcare Service Providers: The healthcare service sector is undergoing significant transformation, driven by increasing demand for value-based care, personalized medicine, and integrated healthcare delivery systems. Tianrong can invest in companies that are developing innovative models of care, such as accountable care organizations (ACOs) and patient-centered medical homes (PCMHs). This strategy requires careful analysis of reimbursement models, regulatory compliance, and patient satisfaction metrics.
- Diversification into International Medical Markets: Expanding its investment focus to international medical markets can provide Tianrong with access to new growth opportunities and reduce its reliance on the U.S. market. Emerging markets such as China, India, and Brazil are experiencing rapid growth in healthcare spending, driven by increasing urbanization, rising incomes, and aging populations. This strategy requires careful assessment of political risks, regulatory differences, and cultural nuances.
What Opportunities Does TIPS Have?
- Investments in emerging medical technologies
- Expansion into telehealth and digital health solutions
- Targeted investments in healthcare service providers
- Diversification into international medical markets
What Threats Does TIPS Face?
- Regulatory risks in the medical sector
- Competition from larger investment firms
- Potential for underperformance relative to parent company expectations
- Economic downturn impacting the medical industry
What Are TIPS's Competitive Advantages?
- Access to capital through Wilton Management Ltd.
- Expertise in identifying and evaluating medical investments.
- Established network within the medical industry.
- Long-term investment horizon.
What Does TIPS Do?
Tianrong Internet Products and Services, Inc., established in 1959, is an investment company primarily focused on allocating capital to businesses within the medical sector. Headquartered in Mountainhome, Pennsylvania, the company's operational structure positions it as a subsidiary of Wilton Management Ltd., a relationship that has been in effect since December 3, 2021. While the company's longevity suggests a history of adapting to evolving market conditions, its current strategy centers on identifying and investing in medical companies, potentially spanning pharmaceuticals, medical devices, healthcare services, or related fields. The company's investment decisions are likely influenced by Wilton Management's broader strategic objectives and resource allocation priorities. Given its small team of two employees, Tianrong likely outsources many functions, focusing on investment selection and oversight.
What Products and Services Does TIPS Offer?
- Invest in medical companies across various sub-sectors.
- Allocate capital to businesses within the healthcare industry.
- Manage a portfolio of medical investments.
- Identify promising medical technologies and companies.
- Oversee the performance of its investment portfolio.
- Operate as a subsidiary of Wilton Management Ltd.
How Does TIPS Make Money?
- Generate revenue through capital appreciation of its investments.
- Receive dividends from its portfolio companies.
- Potentially earn management fees from Wilton Management Ltd.
- Focus on long-term investments in the medical sector.
What Industry Does TIPS Operate In?
Tianrong Internet Products and Services, Inc. operates within the consumer cyclical sector, specifically focusing on specialty retail through its investment activities in the medical industry. The medical sector is characterized by continuous innovation, regulatory scrutiny, and evolving patient needs. Companies in this sector often experience high growth rates but also face significant risks related to clinical trials, product approvals, and market acceptance. The competitive landscape includes established pharmaceutical companies, innovative biotech firms, and healthcare service providers, all vying for market share and investment capital.
Who Are TIPS's Key Customers?
- Wilton Management Ltd. (parent company)
- Portfolio companies in the medical sector
- Shareholders of Wilton Management Ltd.
Company Profile
Tianrong Internet Products and Services, Inc. operates in the Specialty Retail industry within the Consumer Cyclical sector. It is headquartered in Mountainhome, US. The company is led by CEO James A. Tilton. TIPS has traded publicly since 1995.
ROE -3%Key Financial Metrics
Return on equity for Tianrong Internet Products and Services, Inc. stands at -3.3%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 32.6%, showing how much profit it generates from its asset base. TIPS trades at a trailing price-to-earnings ratio of 8.89, below the Consumer Cyclical sector average of ~36x. A current ratio of 0.09 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 11.3%, the inverse of the P/E and a quick read on earnings relative to price.
F-Score 4/9Financial Health
Tianrong Internet Products and Services, Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -13.28 places it in the distress zone, a signal of elevated financial risk.
TIPS Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- High gross margin (97.7%)
- Subsidiary of Wilton Management Ltd.
- Focus on the high-growth medical sector
- Long operating history (established in 1959)
Bear Case
- Negative profit margin (-273.0%)
- Small team (2 employees)
- Reliance on Wilton Management Ltd.
- Limited publicly available information
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
TIPS Latest News
No recent news available for TIPS.
TIPS Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for TIPS.
Price Targets
Wall Street price target analysis for TIPS.
TIPS MoonshotScore
What does this score mean?
The MoonshotScore rates TIPS 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: James A. Tilton
Managing
James A. Tilton serves as the managing person for Tianrong Internet Products and Services, Inc. With a small team of two employees, his role likely encompasses a wide range of responsibilities, from investment strategy and portfolio management to compliance and administrative oversight. His background and experience prior to this role are not detailed in the provided data, but his current position suggests a focus on financial management and investment decisions within the medical sector.
Track Record: Due to the limited information available, it is difficult to assess James A. Tilton's specific track record at Tianrong Internet Products and Services, Inc. His performance is likely closely tied to the overall investment strategy and financial performance of the company, as well as the guidance and support provided by Wilton Management Ltd. Key milestones would include successful investments in medical companies and improvements in the company's financial performance.
TIPS OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Tianrong Internet Products and Services, Inc. may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may be newly formed, distressed, or have limited operating history. Unlike companies listed on major exchanges like the NYSE or NASDAQ, OTC Other companies face fewer regulatory requirements, leading to increased risks for investors due to potential lack of transparency and liquidity.
- OTC Tier: OTC Other
- Limited Disclosure: Lack of financial transparency due to minimal reporting requirements.
- Low Liquidity: Difficulty in buying or selling shares due to low trading volume.
- Price Volatility: Significant price swings due to limited market participation.
- Potential for Fraud: Increased risk of fraudulent activities due to less regulatory oversight.
- Going Concern Risk: Uncertainty about the company's ability to continue operating due to financial challenges.
- Verify the company's legal status and registration.
- Obtain and review any available financial statements.
- Assess the company's management team and their experience.
- Research the company's business model and competitive landscape.
- Evaluate the company's regulatory compliance.
- Understand the risks associated with investing in OTC Other stocks.
- Consult with a qualified financial advisor.
- Subsidiary of Wilton Management Ltd.
- Established in 1959, indicating a long operating history.
- Focus on the medical sector, which has high growth potential.
- Presence of a managing person (James A. Tilton).
Common Questions About TIPS (Consumer Cyclical)
What does Tianrong Internet Products and Services, Inc. do?
Tianrong Internet Products and Services, Inc. functions as an investment entity focused on the medical sector. The company allocates capital to various medical companies, potentially spanning pharmaceuticals, medical devices, healthcare services, and related fields. Operating as a subsidiary of Wilton Management Ltd., Tianrong's investment decisions are likely influenced by its parent company's strategic objectives.
What do analysts say about TIPS stock?
Due to the limited information available and the company's OTC Other listing, there is no readily available analyst coverage for Tianrong Internet Products and Services, Inc. Investors should rely on their own due diligence and financial analysis to assess the company's investment potential.
What are the main risks for TIPS?
The main risks for Tianrong Internet Products and Services, Inc. include its limited liquidity due to trading on the OTC Other market, lack of financial transparency due to minimal reporting requirements, and negative profit margin indicating operational inefficiencies. Additionally, the company's reliance on Wilton Management Ltd. for strategic direction and the volatility inherent in the medical industry pose significant risks.
What are the key factors to evaluate for TIPS?
Evaluate TIPS on fundamentals, analyst consensus, and risk factors. Not financial advice.
How frequently does TIPS data refresh on this page?
TIPS's price was last updated on Jul 20, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven TIPS's recent stock price performance?
Tianrong Internet Products and Services, Inc. (TIPS) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: High gross margin (97.7%). See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider TIPS overvalued or undervalued right now?
Tianrong Internet Products and Services, Inc. (TIPS) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research TIPS before investing?
Before investing in Tianrong Internet Products and Services, Inc. (TIPS), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available due to OTC Other listing and lack of analyst coverage.
- Financial data based on available information and may not be complete.